Methylprednisolone Recall Could Impact Migraine Treatment
Nerve block injections are sometimes used to stop a long Migraine that isn't responding to our regular medications or for Migraine prevention. What's in these injections varies depending on the doctor's preference, but they often contain steroids, including methylprednisolone.
Three lots of methylprednisolone acetate manufactured by the New England Compounding Center have been recalled while FDA and CDC officials investigate an outbreak of a rare fungal form of meningitis that appears to be linked to the methylprednisolone. As of this morning, 35 people in six states have been hit with the rare form of meningitis, and five have died.
The New England Compounding Center has issued a voluntary recall of the three lots of methylprednisolone acetate. The lot numbers for the 80 mg/ml injections are:
Lot #05212012@68, Beyond Use Date (BUD) 11/17/2012
Lot #06292012@26, BUD 12/26/2012
Lot #08102012@51, BUD 2/6/2013
Before accepting any nerve block treatment, be sure to ask what medications are being used. If methylprednisolone is being used, ask to see the medication vial, and check the lot number against those of the recalled lots.
You can find more information about this recall and fungal meningitis on HealthCentral's chronic pain site in Karen Lee Richard's post, Meningitis Outbreak Linked to Steroid Injections for Back Pain.
Please, be careful,
Get the latest Migraine and headache news, informational articles, tips for living well, and more in my free weekly newsletter. To subscribe, CLICK HERE.